PPTA Europe

Nothing is taken more seriously by plasma collection centers than the safety and welfare of plasma donors. Plasmapheresis is a 𝐬𝐚𝐟𝐞 and 𝐞𝐟𝐟𝐢𝐜𝐢𝐞𝐧𝐭 method of obtaining plasma; and it is a central pillar of plasma donation safety. The well-trained staff of plasma centers, combined with rigorous regulatory requirements, and strict industry standards, creates a controlled and safe environment. We deeply appreciate donors' role in saving lives. Making sure the donation experience is safe and enjoyable is a top priority. https://lnkd.in/ekDwY65Y Marilena Vrana Kedrion Biopharma Grifols Takeda #IPAW2024 #PlasmaDonorsSaveLives #ThankYouPlasmaDonors #EUNeedsMorePlasma

I hope to see you in just a few weeks at the #PlasmaProteinForum in #WashingtonDC! This year's event features an excellent roster of informative and insightful speakers and thought-provoking sessions. Registration is open at pptaglobal.org/forum.

We’re wrapping up #HealthLiteracyMonth this October, but let’s keep building our health literacy skills for life!  It’s still a perfect time to talk about how donating plasma can be a great way to stay healthy and save lives. Plus, it might just inspire you to pick up some healthier habits. Find out more! 👇

𝐏𝐥𝐚𝐬𝐦𝐚 𝟏𝟎𝟏 Plasma is the straw-coloured liquid portion of blood. It is the single largest component of blood that acts as a transporting medium for cells and a variety of substances vital to the human body. Some 𝟓𝟓% of blood is plasma. The remaining 𝟒𝟓% is composed of red blood cells, white blood cells and platelets that are suspended in the plasma. __________________________ 𝐏𝐥𝐚𝐬𝐦𝐚 𝐂𝐨𝐦𝐩𝐨𝐬𝐢𝐭𝐢𝐨𝐧 Plasma is primarily made up of water, proteins, and various other components that are essential for the body’s functioning: • 𝟗𝟐% Water • 𝟕% Proteins, including: 🟨 Albumin 🟧 Globulins 🟦 Coagulation factors • 𝟏% Other components, such as: 🟩 Mineral salts 🟧 Sugars 🟪 Fats 🟥 Hormones 🟦 Vitamins __________________________ 𝐏𝐥𝐚𝐬𝐦𝐚 𝐡𝐚𝐬 𝐟𝐨𝐮𝐫 𝐯𝐢𝐭𝐚𝐥 𝐟𝐮𝐧𝐜𝐭𝐢𝐨𝐧𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐡𝐮𝐦𝐚𝐧 𝐛𝐨𝐝𝐲 • Maintaining blood pressure and volume • Helping maintain a proper pH balance in the body • Supplying critical proteins for blood clotting and immunity • Carrying electrolytes such as sodium and potassium to our muscles 𝐋𝐞𝐚𝐫𝐧 𝐦𝐨𝐫𝐞: https://lnkd.in/eBXcS36b ♻ Share this post so others can learn about plasma.

Producing plasma-derived medicinal products (PDMPs) is a complex process that requires the expertise of highly skilled specialists. Plasma is a biologically material, so its collection, processing and conversion into life-saving treatments must be carried out with the utmost precision. This complex work is carried out by a dedicated and skilled workforce. Takeda Grifols Kedrion Biopharma 👇👇

The unpredictability of today’s world has tested every industry. The plasma protein therapeutics sector is no exception. While the sector has proven its resilience during crises such as the COVID-19 pandemic, it is clear that more needs to be done in the coming years to ensure the availability and accessibility of plasma-derived medicines (PDMPs). More people are diagnosed with conditions treatable by PDMPs each year. PDMPs are already used for a diverse range of medical applications, and ongoing research will likely expand their uses even further. Marilena Vrana

As we gear up for the launch of the #RareDiseaseDay 2025 campaign, it’s a great time to reflect on what Rare Disease Day is and why it matters. This global movement aims to increase understanding of the lives of people living with rare diseases, alongside their families, friends, and caregivers. Each year, events take place around the world, with an incredible 106 countries showing solidarity with the rare disease community. With 300 million people living with one or many of over 6,000 rare conditions, raising awareness and fighting for change is crucial. That’s the core mission of Rare Disease Day. Falling on the last day of February every year, Rare Disease Day 2025 will be marked on 28th February. #RareDiseaseDay2025 #awareness #change

Type 3 is the rarest and most severe form of Von Willebrand disease (VWD). People with this type have very low levels or complete absence of Von Willebrand factor (VWF). Symptoms are often severe and include spontaneous bleeding episodes. Learn more at: https://lnkd.in/emwdXubt     National Bleeding Disorders Foundation 

What a productive visit to the PPTA Europe Brussels office!     Throughout the week, I collaborated with staff to closely examine the European political scene and analyzed current developments and future challenges impacting the plasma industry. Together, we reviewed PPTA’s ongoing European initiatives and planned strategic activities at both EU and national levels. We set clear priorities for Q4 2024 and 2025, and I am particularly excited about how we are strengthening cross-functional collaboration and agility. As always, we will continue to work closely with our member companies and engage with policymakers and stakeholders to ensure a stable plasma supply and improve access to plasma-derived medicinal products.